🇺🇸 FDA
Patent

US 10206875

Nanoemulsion compositions of taxoid drugs, and methods for the use thereof to target cancer cells and cancer stem cells

granted A61KA61K31/337A61K47/12

Quick answer

US patent 10206875 (Nanoemulsion compositions of taxoid drugs, and methods for the use thereof to target cancer cells and cancer stem cells) held by Northwestern University expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Feb 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
53
CPC classes
A61K, A61K31/337, A61K47/12, A61K47/44, A61K47/542